Skip to main content
. 2016 Dec 12;6:38901. doi: 10.1038/srep38901

Figure 3.

Figure 3

(A) 5-year CSSs in all patients between lymph node count ≥9 and <9. (B) 5-year CSSs in patients with stage I between lymph node count ≥9 and <9. (C) 5-year CSSs in patients with stage II between lymph node count ≥9 and <9. (D) 5-year CSSs in patients with stage III between lymph node count ≥9 and <9.